Clinical Trial Update: New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating a tablet combining two FDA-approved antiretroviral drugs for ART-experienced HIV-1 infected subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Two FDA-approved antiretroviral drugs (combined tablet)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 3 | Status: COMPLETED